Women diagnosed in adulthood with Attention Deficit Hyperactivity Disorder (ADHD) are encouraged to join a University of Queensland study into the impact of the diagnosis.
A deal? An asset sale? A launch? Everyone is watching next moves for Roivant, BridgeBio
What’s next for two of biotech’s once-cool, now-hot companies? Hot on the heels of critical data readouts, Roivant Sciences and BridgeBio Pharma are enjoying two